I Lecander — Endo Lab

observational 1998

Fibrinolysis in the peritoneal fluid during adhesions, endometriosis and ongoing pelvic inflammatory disease

Inflammation ·doi:10.1023/a:1022322814288

The concentrations of the specific activators (u-PA and t-PA) and the specific inhibitors (PAI-1 and PAI-2) of the fibrinolytic system were analyzed in the peritoneal fluid in women suffering from intra-abdominal adhesions, endometriosis or…

observational 1998

Fibrinolytic factors in endometriotic tissue, endometrium, peritoneal fluid, and plasma from women with endometriosis and in endometrium and peritoneal fluid from healthy women

Fertility and sterility ·doi:10.1016/s0015-0282(98)00285-4

OBJECTIVE: To determine whether there is a difference in fibrinolytic compounds in endometriotic tissue, endometrium, peritoneal fluid (PF), and plasma from women with endometriosis and in endometrium and PF from healthy women. DESIGN: Pro…

other 1981

Urokinase-like plasminogen activator as a marker of endometrial neoplasia

Cancer ·doi:10.1002/1097-0142(19810915)48:6<1484::aid-cncr2820480634>3.0.co;2-l

Urokinase-like plasminogen activator (ULPA) was determined with a radioimmunoassay in uterine aspirates from 67 patients prior to curettage. In women with normal endometrial histology the mean concentration of ULPA was 5.4 +/- 2.5 microgram…